<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B92C1E49-4D20-4A69-BDBE-BDEC1AE2A476"><gtr:id>B92C1E49-4D20-4A69-BDBE-BDEC1AE2A476</gtr:id><gtr:name>University Medical Centre Utrecht</gtr:name><gtr:address><gtr:line1>Unversity Medical Centre Utrecht</gtr:line1><gtr:line2>Rudolf Magnus Institute for Neuroscience</gtr:line2><gtr:line3>PO Box 85060</gtr:line3><gtr:postCode>NL-3508 AB</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:department>School of Medicine</gtr:department><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B92C1E49-4D20-4A69-BDBE-BDEC1AE2A476"><gtr:id>B92C1E49-4D20-4A69-BDBE-BDEC1AE2A476</gtr:id><gtr:name>University Medical Centre Utrecht</gtr:name><gtr:address><gtr:line1>Unversity Medical Centre Utrecht</gtr:line1><gtr:line2>Rudolf Magnus Institute for Neuroscience</gtr:line2><gtr:line3>PO Box 85060</gtr:line3><gtr:postCode>NL-3508 AB</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6334DE2E-F021-43C3-8F90-D4BD40D0B7C6"><gtr:id>6334DE2E-F021-43C3-8F90-D4BD40D0B7C6</gtr:id><gtr:firstName>Clare</gtr:firstName><gtr:surname>Logan</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/CE3C45E9-3277-45F6-A6CF-80DF58376716"><gtr:id>CE3C45E9-3277-45F6-A6CF-80DF58376716</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>Francis</gtr:otherNames><gtr:surname>Inglehearn</gtr:surname><gtr:orcidId>0000-0002-5143-2562</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F2890749-78F4-4963-BF4A-CE451D546D8D"><gtr:id>F2890749-78F4-4963-BF4A-CE451D546D8D</gtr:id><gtr:firstName>Eamonn</gtr:firstName><gtr:surname>Sheridan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2DD63050-A3E9-4C9F-B1F7-4D08FCC320D1"><gtr:id>2DD63050-A3E9-4C9F-B1F7-4D08FCC320D1</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:otherNames>Michael</gtr:otherNames><gtr:surname>Carr</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C33ADE86-8A98-4E73-968D-29213889E986"><gtr:id>C33ADE86-8A98-4E73-968D-29213889E986</gtr:id><gtr:firstName>David Alasdair</gtr:firstName><gtr:surname>Parry</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BE699B72-A37B-46BC-AA51-5D7D78EC44E6"><gtr:id>BE699B72-A37B-46BC-AA51-5D7D78EC44E6</gtr:id><gtr:firstName>Colin</gtr:firstName><gtr:otherNames>Anfimov</gtr:otherNames><gtr:surname>Johnson</gtr:surname><gtr:orcidId>0000-0002-2979-8234</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FK011154%2F1"><gtr:id>6C01E8A5-A5FB-45F6-8F0A-B9665762F459</gtr:id><gtr:title>Ciliopathy disease gene identification by whole exome medical resequencing</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K011154/1</gtr:grantReference><gtr:abstractText>Cilia are finger-like projections from cells that act as a cellular &amp;quot;antenna&amp;quot; to detect and respond to chemical or mechanical cues. One important cue is fluid flow during the process of establishing asymmetry during early embryogenesis, the formation of the kidney nephron, and the formation of other tubular structures such as the neural tube. A group of comparatively common inherited conditions called &amp;quot;ciliopathies&amp;quot; can arise when the structure or function of cilia are defective. For example, cystic kidney disease is a common feature of many ciliopathies, often leads to kidney failure, and is therefore a significant cause of childhood disease and death. The most severe ciliopathy (&amp;quot;Meckel-Gruber syndrome&amp;quot;) also involves problems in the development of the brain and spinal cord (called &amp;quot;neural tube defects&amp;quot;) that arise during growth of babies in the womb. Reduced or absent mucus clearance from the lungs is the main consequence in other ciliopathies (&amp;quot;primary ciliary dyskinesia&amp;quot;), which causes recurrent respiratory infections and progressive damage to the respiratory system. In many ciliopathies, there are disturbances in the patterns of left-right organization of the lungs and heart, which are also seen in congenital heart defects (CHD), the most common birth defect.

This research proposes to identify many of the remaining disease genes that are defective (&amp;quot;mutated&amp;quot;) in this group of ciliopathies. To achieve this aim, we will take advantage of recent exciting advances in genetic technology that allow us to analyze the entire coding parts of a patient's genome (&amp;quot;whole exome sequencing&amp;quot;). We are uniquely placed to do this work and have a proven track record of success in this field: we have formed excellent research partnerships with families and their clinicians in the local community to participate in gene identification studies, and we have the appropriate state-of-the-art technology, computer analysis tools and experience.

The identification of a new ciliopathy gene provides two major benefits. Firstly, accurate genetic testing then becomes possible for patients and families, with improvements in diagnosis and genetic counselling. Secondly, important and often unexpected scientific insights are made into the disease mechanism of the ciliopathy and into the normal function of the disease gene, which can lead to new treatments. We also expect new insights into the causes of other, more common conditions such as polycystic kidney disease, spina bifida and congenital heart defects.</gtr:abstractText><gtr:technicalSummary>We have ascertained and sampled DNA from about 250 individuals with a broad range of known or suspected ciliopathy phenotypes, but with a common theme of left-right laterality defects. These patients are confirmed to be mutation negative for known genes, or have been excluded from linkage to known loci in multiplex or consanguineous families. About 50% of disease genes for Meckel-Gruber syndrome and primary ciliary dyskinesia still remain to be identified, and many families with inherited forms of left-right laterality defects have an unknown genetic aetiology. We estimate that this research will identify a minimum of 10-12 new genes, comprising the majority of the remaining genes in this group of conditions. To discover new ciliopathy genes, we will perform whole exome sequencing for 100 individuals, including trios with an orphan ciliopathy. We will use our own successful bioinformatics workflow to distinguish putative pathogenic mutations from benign polymorphisms, even in the context of genetic heterogeneity. We will prioritize potential pathogenic variants in functional candidate genes on the basis of putative function, and our own data from a reverse genetics screen for ciliogenesis. Collaboration with other groups will allow us identify further mutations in a new gene for cohorts of patients with a ciliopathy and/or a retinal degeneration. This will also delineate an allelic series for a new gene, and may define genotype-phenotype correlations. We will collaborate with external groups to assess zebrafish embryo morphant phenotypes for 2 or 3 newly-identified ciliopathy disease genes. In some instances (for example if we need to prove the pathogenicity of a missense mutation), we will perform straight-forward functional characterization of the protein. This will include sub-cellular localization using confocal immunofluorescence microscopy and the effect of RNAi or a missense mutation on ciliogenesis or protein localization.</gtr:technicalSummary><gtr:potentialImpactText>Whole exome sequencing is very likely to improve the rate of molecular diagnosis in children with a known or suspected ciliopathy, and reduce the burden and disruption of a &amp;quot;diagnostic odyssey&amp;quot; for families. For clinicians, the identification of a new gene can also reduce misdiagnosis or late diagnosis, inform the establishment of proper care pathways for ciliopathy patients, and prioritize those patients that can most benefit from future targeted therapies. For example, patients with congenital heart disease (CHD) and heterotaxy have a high postsurgical morbidity and mortality, often developing respiratory complications, so prescreening for ciliary dysfunction or mutations in a ciliopathy gene may be of great potential benefit for CHD patients. CHD is the most common birth defect, affecting 1 in 150 live births or 3600 patients a year in the UK.
In families with a ciliopathy, the identification of a novel disease gene immediately permits the offer of genetic testing to at-risk relatives. Carrier tests and prenatal diagnosis can also encourage informed reproductive choices for families. In our experience, once a disease gene has been identified, genetic testing on a research basis can be applied immediately, and translation into service provision through an accredited NHS diagnostic lab can be made available in months. As a direct outcome of our own previous research, we have established UK-wide testing for Alstr&amp;ouml;m syndrome, Aicardi-Gouti&amp;egrave;res syndrome and Meckel-Gruber syndrome (through the UK Genetic Testing Network and based at Yorkshire Regional Clinical Genetics Service). From our experiences of establishing NHS service testing using next-generation clonal sequencing at Yorkshire Regional Clinical Genetics Service, we fully expect that whole exome sequencing (&amp;quot;clinical exomes&amp;quot;) will out-perform conventional diagnostic testing in terms of speed, sensitivity and cost. There are therefore considerable potential cost savings for NHS Trusts, but the fundamental chaenge in analyzing exome sequence data is then distinguishing pathogenic mutations from benign polymorphisms, particularly in the context of genetically heterogeneous conditions such as the ciliopathies. Our ability to overcome this challenge will inform the debate on the eventual clinical utility and clinical validity of &amp;quot;clinical exomes&amp;quot;, and the probable widespread adoption of whole exome sequencing as a routine diagnostic strategy. In particular, we are keen to retain key researchers with key bioinformatic skills so that their knowledge can stimulate the adoption of clinical bioinformatics expertise, and the use of standardized databases of normal and pathogenic genomic variation. The development of a robust interface between research and diagnostic development work is therefore an indirect but important added benefit of this research, which should encourage the implementation of NGS for the diagnosis of genetic diseases in other clinical centres.
The identification of further novel ciliopathy disease genes may also enable the future rational design of therapeutics to modify or treat cystic kidney disease or ciliopathy disease progression, or the long-term outlook of patients with these conditions. Since most of these conditions are autosomal recessive and are the result of absence of normal protein, rather than the presence of an abnormal protein, they can in principle be corrected by gene-replacement, a therapeutic approach now undergoing Phase II clinical trials in major centres in the US, UK and elsewhere. Patients in whom mutations are found can therefore be given a clearer prognosis and prioritised for these new treatments, making recessive disease a top priority for further characterization.</gtr:potentialImpactText><gtr:fund><gtr:end>2016-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>477675</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Developmental and Biomedical Genetics</gtr:department><gtr:description>zebrafish models of human disease</gtr:description><gtr:id>A63733B8-3221-4803-9150-54A62FDC5C15</gtr:id><gtr:impact>two manuscripts in the drafting stage, reporting novel genes mutated in a retinal dystrophy and Meckel-Gruber syndrome (a severe ciliopathy), and a form of primary ciliary dyskinesia that manifests only with cardiac heterotaxy</gtr:impact><gtr:outcomeId>Yyyo6hfNC6p-2</gtr:outcomeId><gtr:partnerContribution>access to zebrafish husbandry and microinjection facilities; assessment of embryo phenotypes</gtr:partnerContribution><gtr:piContribution>candidates genes with putative pathogenic mutations for recessive developmental or cardiac conditions are modelled in wild-type zebrafish embryos using morpholino knockdown, or novel mutations are knocked-in using the CRISPR-Cas9 system</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Medical Center Utrecht (UMC)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>zebrafish models of human disease</gtr:description><gtr:id>61329D5C-3DEB-4CC8-B9EF-57FF904B89E9</gtr:id><gtr:impact>two manuscripts in the drafting stage, reporting novel genes mutated in a retinal dystrophy and Meckel-Gruber syndrome (a severe ciliopathy), and a form of primary ciliary dyskinesia that manifests only with cardiac heterotaxy</gtr:impact><gtr:outcomeId>Yyyo6hfNC6p-3</gtr:outcomeId><gtr:partnerContribution>access to zebrafish husbandry and microinjection facilities; assessment of embryo phenotypes</gtr:partnerContribution><gtr:piContribution>candidates genes with putative pathogenic mutations for recessive developmental or cardiac conditions are modelled in wild-type zebrafish embryos using morpholino knockdown, or novel mutations are knocked-in using the CRISPR-Cas9 system</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Genetic Medicine</gtr:department><gtr:description>zebrafish models of human disease</gtr:description><gtr:id>56A14638-0D45-4072-97CE-BE7B436102E1</gtr:id><gtr:impact>two manuscripts in the drafting stage, reporting novel genes mutated in a retinal dystrophy and Meckel-Gruber syndrome (a severe ciliopathy), and a form of primary ciliary dyskinesia that manifests only with cardiac heterotaxy</gtr:impact><gtr:outcomeId>Yyyo6hfNC6p-1</gtr:outcomeId><gtr:partnerContribution>access to zebrafish husbandry and microinjection facilities; assessment of embryo phenotypes</gtr:partnerContribution><gtr:piContribution>candidates genes with putative pathogenic mutations for recessive developmental or cardiac conditions are modelled in wild-type zebrafish embryos using morpholino knockdown, or novel mutations are knocked-in using the CRISPR-Cas9 system</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Joubert syndrome scientific meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>01FC24D6-A90C-40D7-8D07-F0FEDF660912</gtr:id><gtr:impact>imporant discussion on the improved methods for diagnosis of Joubert syndrome and other ciliopathies, as well as new insights into pathogenic mechanisms

promoting new collaborations with workers in the field of Joubert syndrome</gtr:impact><gtr:outcomeId>544e1e94ebecb6.70255505</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ISN Forefronts Symposium on PKD</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3D9FCC5B-21CC-4F68-9CD8-EEDBC658CC7C</gtr:id><gtr:impact>a general overview of my group's work on Meckel-Gruber syndrome and other ciliopathies, to an audience of researchers and clincians working on Polycystic Kidney Disease

the meeting was very useful as an informal venue to establish new collaborations with some existing collaborators</gtr:impact><gtr:outcomeId>88DE698B804</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>genetics and cell biology of Meckel-Gruber syndrome</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>58E405A0-8D4A-47CC-879F-9D849B17283A</gtr:id><gtr:impact>a overview of the molecular genetics and cell biology of ciliopathies, focussing on Meckel-Gruber syndrome, to an audience of medical and clinical geneticists

useful to establish clinical collaborations on other ciliopathies (notably family ascertainment for Ivemark syndrome)</gtr:impact><gtr:outcomeId>7EC27A57B47</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>autozygosity.org website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>91701377-7A4A-4F67-A400-CDC49F1C969F</gtr:id><gtr:impact>a website inititated and maintained by Prof. David Bonthron at the University of Leeds to summarize our work on autozygosity mapping of recessive inherited conditions

increased clinical collaboration and publicity</gtr:impact><gtr:outcomeId>9BF4F3F02C6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.autozygosity.org</gtr:url><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Ciliopathy Alliance UK</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A659FE44-AFE9-452B-9692-B47C76F9ADF0</gtr:id><gtr:impact>promoted support group attendance at the international conference &amp;quot;Cilia 2012&amp;quot; in London 2012

continuing links with support groups (Joubert Syndrome UK and Alstrom Syndrome UK)</gtr:impact><gtr:outcomeId>AhczipVfHr8</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cilia in Development and Disease</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BC2A5C6E-3002-4BA2-8DC2-08AB47C9CEEC</gtr:id><gtr:impact>contributed to organization and programme for these international conferences

new research collaborations were started as a result of these conferences</gtr:impact><gtr:outcomeId>544e1b4861eed6.71171825</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>school out-reach activities</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>93C36386-F769-42DC-9A47-2A982AA1DDE7</gtr:id><gtr:impact>discussed careers in medical research with about 60 Year 12 and 13 students on a visit and presentation at their school; 10 had a follow-on visit to the lab to discuss research methods</gtr:impact><gtr:outcomeId>56ddc9e73d7017.81273560</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Midbrain/Hindbrain Malformations and Hydrocephalus workshop</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DBB9ECF2-51A9-4DF4-A492-87E7C0DB53DF</gtr:id><gtr:impact>important opportunity to compare methods of diagnosis for ciliopathies and provided new insights into development of the cerebullum and posterior fossa structures

initiated new collaborations as part of on-going discussions</gtr:impact><gtr:outcomeId>544e1d05876b14.61842552</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>FASEB &quot;Polycystic Kidney Disease&quot; meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>31F23392-2736-498D-8E5B-EC1EAEC38314</gtr:id><gtr:impact>to facillitate and establish research collabirations, with critique of current research</gtr:impact><gtr:outcomeId>58c01acce22f71.80700232</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>576400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Bilateral BBSRC-SFI (structure-function relationships in the ciliary transition zone)</gtr:description><gtr:end>2021-03-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/P007791/1</gtr:fundingRef><gtr:id>6CF11FDC-384E-487D-8D60-5A5C19A955CC</gtr:id><gtr:outcomeId>58c01675130c99.32856439</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>856000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC project grant (functional genomics)</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M000532/1</gtr:fundingRef><gtr:id>177FA334-2A63-4E34-8A92-797B0D2E0527</gtr:id><gtr:outcomeId>544e17f6664ee2.47116840</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>recessive conditions</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>9FC79F70-266A-4F9D-93F5-7435265E2FAD</gtr:id><gtr:impact>greater investment in clinical genetics and training of genetic counsellors, greater awareness of recessive conditions and rare diseases</gtr:impact><gtr:outcomeId>7F48BC9BDA7</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>diagnosis and treatment of neurodevelopmental conditions</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8FBD5AC3-E5FD-4FD7-A80B-A3812AB57E70</gtr:id><gtr:impact>Our research has enabled a new recognition of the broad range of phenotype for neurodevelopmental conditions such as Joubert syndrome. The identification of new genes provided more accurate prognostic testing and genetic counselling, with national NHS service testing for both Meckel-Gruber and Joubert syndromes now based at Yorkshire Regional Genetics Service. New services based on clinical whole exome sequencing has enabled testing of about 40-60 patients per annum for both the UK and for international referrals.</gtr:impact><gtr:outcomeId>544e2372ee2d89.96154444</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>First use of clinical whole exome sequencing by the Yorkshire Regional Genetics Service for the diagnosis of ciliopathies (primary ciliary dyskinesia, Meckel-Gruber syndrome, Joubert syndrome). New services based on clinical whole exome sequencing has enabled testing of about 40-60 patients per annum for both the UK and for international referrals.</gtr:description><gtr:id>E435F804-03C2-4344-B1E3-5A718F961B05</gtr:id><gtr:impact>Improved diagnosis, prognosis and genetic counselling for ciliopathy patients and their families</gtr:impact><gtr:outcomeId>544e29eb280c84.94734723</gtr:outcomeId><gtr:stage>Wide-scale adoption</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>NHS service testing for ciliopathies</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:url>http://www.leedsth.nhs.uk/a-z-of-services/molecular-genetics/test-pages/meckel-and-joubert-syndromes/</gtr:url><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>list of validated candidate genes implicated in ciliogenesis, cilia maintenance and cilia length growth as a result of a whole genome cell-based reverse genetics visual screen
primary list: ca. 600 genes
secondary screen list: 174 genes
tertiary validated genes: ca. 42 genes
selected functional candidates: 14 genes
other date includes RNA-Seq expression data from non-ciliated vs. ciliated cell-lines</gtr:description><gtr:id>E48E5167-B43A-449D-B6D3-EC5BC7439B59</gtr:id><gtr:impact>Wheway G*, Schmidts M*, Mans DA*, Szymanska K*, Nguyen T-MT*, ...69 others... Doherty D+, Mitchison HM+, Roepman R+, Johnson CA+ (2015). An siRNA-based functional genomics screen for the identification of regulators of ciliogenesis and ciliopathy genes. Nat. Cell. Biol. 17: 1074-87</gtr:impact><gtr:outcomeId>544e284e9c2d84.58768687</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>effectors of ciliogenesis</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>cohort of ciliopathy patients, sampled for DNA with assessment of mutation status and clinical phenotype</gtr:description><gtr:id>CDD7CE6F-20FC-4808-8C61-A83D229F1D27</gtr:id><gtr:impact>role of RPGRIP1L in determining a retinal phenotype in ciliopathies; mutation screening in other ciliopathy genes eg ARL13B, TMEM216, TMEM138. TMEM237 etc</gtr:impact><gtr:outcomeId>BDC574405C5</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MKS patient cohort</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>developed standard workflow for analysis of variants from WES experiments based on existing publically-available databases (EVS, 1000 Genomes etc) and in-house ethnically-matched exomes
bespoke Perl scripts developed to allow automated annotation of candidate genes, pathogenic potential of variants (from Condel, Polyphen etc), segregation analysis in small families with recessive or dominant inheritance patterns</gtr:description><gtr:id>204ED430-B36D-4810-8908-29377A492AF8</gtr:id><gtr:impact>Parry DA,et al. (2013). SAMS, a syndrome of short stature, auditory canal atresia, mandibular hypoplasia and skeletal abnormalities is a unique neurocristopathy caused by mutations in Goosecoid. Am. J. Hum. Genet. in press

Khan K, et al. (2012). Next generation sequencing identifies mutations in Atonal homolog 7 (ATOH7) in families with global eye developmental defects. Hum Mol Genet. 21: 776-83.

Logan CV, et al. (2011). Mutations in MEGF10, a regulator of satellite cell myogenesis, cause early-onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD). Nat. Genet. 43: 1189-1192</gtr:impact><gtr:outcomeId>DPAcJucEcc6</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>WES variant analysis and filtering</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://autozygosity.org</gtr:url><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>list of validated candidate genes implicated in ciliogenesis, cilia maintenance and cilia length growth as a result of a whole genome cell-based reverse genetics visual screen
primary list: ca. 600 genes
secondary screen list: 174 genes
tertiary validated genes: ca. 42 genes
selected functional candidates: 14 genes
other date includes RNA-Seq expression data from non-ciliated vs. ciliated cell-lines</gtr:description><gtr:id>DA951BBD-4435-4462-8EEC-E1117518503D</gtr:id><gtr:impact>methodlogy of assessing cell numbers in the screen described in this publication:
Elmehdawi F, et al. (2013) Human Homologue of Drosophila Ariadne (HHARI) is a marker of cellular proliferation associated with nuclear bodies. Exp. Cell Res. 319:161-172.
Wheway G, et al. (2015). An siRNA-based functional genomics screen for the identification of regulators of ciliogenesis and ciliopathy genes. Nat. Cell. Biol. 17: 1074-87</gtr:impact><gtr:outcomeId>A8dhmsQbhta</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>effectors of ciliogenesis</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.syscilia.org</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>AD5A1768-1EA4-4387-81D2-5F49A8F4942A</gtr:id><gtr:title>Unraveling the genetics of Joubert and Meckel-Gruber syndromes.</gtr:title><gtr:parentPublicationTitle>Journal of pediatric genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b747d6deb8ac6a37c79ace3770a47793"><gtr:id>b747d6deb8ac6a37c79ace3770a47793</gtr:id><gtr:otherNames>Szymanska K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2146-460X</gtr:issn><gtr:outcomeId>5675e04229a96</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C305F8BD-A7F9-460A-87A3-C745472FA9CF</gtr:id><gtr:title>An siRNA-based functional genomics screen for the&amp;nbsp;identification of regulators of ciliogenesis and ciliopathy&amp;nbsp;genes.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4d4fde27c120458c908f10c2d63a3bc"><gtr:id>a4d4fde27c120458c908f10c2d63a3bc</gtr:id><gtr:otherNames>Wheway G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>5675e8444eb92</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25ADCC64-44F8-4184-A798-B5A197AF94CE</gtr:id><gtr:title>Mutations in CSPP1, encoding a core centrosomal protein, cause a range of ciliopathy phenotypes in humans.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/980649fdebe617988fd56ee6e43b2a7e"><gtr:id>980649fdebe617988fd56ee6e43b2a7e</gtr:id><gtr:otherNames>Shaheen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>544e13edb68831.83666745</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B3F535B-23C6-40C5-8DFC-009B5A56FE29</gtr:id><gtr:title>Medical genetics of ciliopathies.</gtr:title><gtr:parentPublicationTitle>Journal of pediatric genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94c488a029ceee4f6bd82eedbc6b0eea"><gtr:id>94c488a029ceee4f6bd82eedbc6b0eea</gtr:id><gtr:otherNames>Mans DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2146-460X</gtr:issn><gtr:outcomeId>5675de0b518cd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28C332F9-AF4E-477F-AF72-C39315D9D089</gtr:id><gtr:title>Screen-based identification and validation of four new ion channels as regulators of renal ciliogenesis.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c22bb1c7d32d092facd7038027dc703"><gtr:id>1c22bb1c7d32d092facd7038027dc703</gtr:id><gtr:otherNames>Slaats GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>56ddb6af5aea49.45683825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FEC8B91-3289-49AF-97C6-1EAC0410A979</gtr:id><gtr:title>Mutation screening of retinal dystrophy patients by targeted capture from tagged pooled DNAs and next generation sequencing.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06de555983d39c5037a4e4ce5a4f8442"><gtr:id>06de555983d39c5037a4e4ce5a4f8442</gtr:id><gtr:otherNames>Watson CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>544e12a47491a7.25458714</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4660B0F-7B02-441E-957F-1FDD43427E93</gtr:id><gtr:title>TMEM107 recruits ciliopathy proteins to subdomains of the ciliary transition zone and causes Joubert&amp;nbsp;syndrome.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1dd633d616ef127bd109a4b2fd7d283"><gtr:id>f1dd633d616ef127bd109a4b2fd7d283</gtr:id><gtr:otherNames>Lambacher NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>56ddb6af78f3a1.31834245</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43BCFAED-B477-4B15-AFB8-E69B5D7DE667</gtr:id><gtr:title>Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69719be8c0d997003b15d9b90bc3e6af"><gtr:id>69719be8c0d997003b15d9b90bc3e6af</gtr:id><gtr:otherNames>Logan CV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>544e14f9094e78.75162018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B116A7D-F5B5-41AA-8359-65ECBFC987B0</gtr:id><gtr:title>The role of primary cilia in the development and disease of the retina.</gtr:title><gtr:parentPublicationTitle>Organogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4d4fde27c120458c908f10c2d63a3bc"><gtr:id>a4d4fde27c120458c908f10c2d63a3bc</gtr:id><gtr:otherNames>Wheway G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1547-6278</gtr:issn><gtr:outcomeId>pm_12483_23_24162842</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>383D44AB-C412-4C73-9DB7-56F5874B92BA</gtr:id><gtr:title>Characterizing the morbid genome of ciliopathies.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/980649fdebe617988fd56ee6e43b2a7e"><gtr:id>980649fdebe617988fd56ee6e43b2a7e</gtr:id><gtr:otherNames>Shaheen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>58c00b9d344878.47175534</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>378CC30E-7111-4508-B687-2070181885DF</gtr:id><gtr:title>Mutations in GPAA1, Encoding a GPI Transamidase Complex Protein, Cause Developmental Delay, Epilepsy, Cerebellar Atrophy, and Osteopenia.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ffedb8461ec086724bc5b3d32ca3d032"><gtr:id>ffedb8461ec086724bc5b3d32ca3d032</gtr:id><gtr:otherNames>Nguyen TTM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5a9d540f4dffd2.73741320</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84B6341A-C972-47A6-8F71-D924B3E50FBD</gtr:id><gtr:title>DNAAF1 links heart laterality with the AAA+ ATPase RUVBL1 and ciliary intraflagellar transport.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dd8d87821e43a0a31b54946f71919f8"><gtr:id>1dd8d87821e43a0a31b54946f71919f8</gtr:id><gtr:otherNames>Hartill VL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5a9d543d6d00d0.90096821</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24B1F413-C377-4667-868C-7D85F5BC1510</gtr:id><gtr:title>Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII a1 Chain.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69719be8c0d997003b15d9b90bc3e6af"><gtr:id>69719be8c0d997003b15d9b90bc3e6af</gtr:id><gtr:otherNames>Logan CV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>56ddb6af1f59a7.35194222</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78AEEFF9-3728-43AA-8753-2D65D3406880</gtr:id><gtr:title>MKS1 regulates ciliary INPP5E levels in Joubert syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c22bb1c7d32d092facd7038027dc703"><gtr:id>1c22bb1c7d32d092facd7038027dc703</gtr:id><gtr:otherNames>Slaats GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>585d5682e940f8.18650546</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E22EBDD4-B7D0-43C3-9611-118F1B111922</gtr:id><gtr:title>De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab132ebc438f29b840b89123febb1664"><gtr:id>ab132ebc438f29b840b89123febb1664</gtr:id><gtr:otherNames>Mirzaa G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>544e13ed53c036.51034047</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>550784C9-65E3-41B6-8A27-0DAE32D80884</gtr:id><gtr:title>Fifteen years of research on oral-facial-digital syndromes: from 1 to 16 causal genes.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bea432167784c14ab151f03355718aa7"><gtr:id>bea432167784c14ab151f03355718aa7</gtr:id><gtr:otherNames>Bruel AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>5a9d538378b2f9.06310126</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K011154/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>78FE8F42-8AFB-48F8-8662-37D541AD95BF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Congenital Disorders</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>